查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2030627

藥品活性成分（API）市場：規模、佔有率、趨勢和行業分析報告（按產品類型、劑型、生產商類型、應用和地區分類）- 市場預測（2026-2034 年）

Active Pharmaceutical Ingredient (API) Market Size, Share, Trends, Industry Analysis Report By Product Type, By Form (Aqueous, Non-Aqueous Liquid, Dry Powder), By Manufacturer Type, By Application, By Region - Market Forecast, 2026-2034
出版日期: | 出版商: Polaris Market Research | 英文 120 Pages | 商品交期: 最快1-2個工作天內

價格

預計到2034年，活性藥物成分（API）的市場規模將達到4,680億美元。本報告詳細分析了當前的市場動態，並對未來的市場成長進行了展望。

活性藥物成分（API）市場的成長主要受全球對學名藥和非處方藥（OTC）需求不斷成長的推動。例如，美國非處方藥零售額從2000年的147億美元增加到2023年的434億美元，增幅高達330億美元。此外，2018年至2023年間，成藥銷售額成長了3.6%。

來自公共和私人投資者的投資和資金籌措增加預計將推動醫藥市場強勁成長。製劑技術和生產流程的進步，以及藥物研發週期的縮短，正吸引著尋求更高投資回報的投資者的目光。例如，2024年8月，注射劑領域的主要企業Vivint Pharma宣布計劃在海德拉巴的基因組谷（Genome Valley）建造一座最先進的注射劑生產設施。該公司計劃投資4,800萬美元建造這座新設施，預計將創造1,000個就業崗位，並鞏固特倫甘納邦作為全球生命科學中心的地位。該消息是在美國舉行的特倫甘納邦首席部長A. Levantha Reddy與工業和商業部長D. Sridhar Bab的高級別會晤期間宣布的。 Vivint Pharma已在基因組谷擁有一座價值850萬美元的研發中心，目前正在擴大在印度的業務。該公司已在以世界一流的基礎設施和創新生態系統而聞名的基因組谷購買了 5.5 英畝土地，以支持其向國際市場的擴張。

製藥公司既是活性藥物成分（API）的主要消費商，也是主要生產商。投資增加和政府獎勵措施促使許多擁有創新理念的新參與企業進入市場，對老牌製藥巨頭構成挑戰。

藥品活性成分（API）市場報告要點

按劑型分析，水性劑型預計將在市場中顯著成長，複合年成長率 (CAGR) 將相當可觀。這一成長主要歸功於水性活性成分在各種劑型藥物中的廣泛應用。

2024年，由於北美地區多家公司的強大實力，北美在API市場佔據主導地位。

由於國內對生物技術創新的監管支持和資金投入，中國原料藥市場預計將迎來顯著成長。

主要市場參與者包括輝瑞、梯瓦製藥工業、葛蘭素史克、賽諾菲、禮來公司、默克、艾伯維、羅氏、Astra Zeneca、BASF博士實驗室、巴斯夫、太陽製藥工業、Curia Global 和南京健友生化製藥有限公司。

目錄

第1章 引言

第2章執行摘要

第3章：調查方法

第4章：全球醫藥活性成分（API）市場洞察

  • 市場概覽
  • 藥品活性成分（API）市場的市場動態
    • 促進者和機會
      • 對製藥業的投資增加正在推動市場規模擴大。
      • 正在研發的藥物數量不斷增加，推動了市場成長。
    • 抑制因素和挑戰
      • 熟練勞動力短缺
  • PESTEL 分析
  • 原料藥（API）市場趨勢
  • 價值鏈分析
  • 新冠疫情影響分析

第5章 全球活性藥物成分（API）市場：依產品類型分類

  • mAb
  • 免疫球蛋白
  • 細胞激素
  • 胰島素
  • 肽激素
  • 血液因子
  • 胜肽類抗生素
  • 疫苗
  • 小分子抗生素
  • 高效活性藥物原料藥（HPAPI）
  • 其他

第6章 全球活性藥物成分（API）市場：以劑型分類

  • 水溶液
  • 非水液體
  • 乾粉

第7章 全球活性藥物成分（API）市場：按製造商類型分類

  • 內部生產
  • 面向大眾

第8章 全球活性藥物成分（API）市場：按應用分類

  • 循環系統
  • 腫瘤學
  • 中樞神經系統和神經病學
  • 整形外科
  • 內分泌學
  • 呼吸內科
  • 胃腸病學
  • 腎臟病學
  • 眼科
  • 其他

第9章 全球活性藥物成分（API）市場：按地區分類

  • 北美洲
    • 北美：依產品類型分類，2021-2034 年
    • 北美：以劑型分類，2021–2034 年
    • 北美：依製造商類型分類，2021-2034 年
    • 北美：依申請，2021-2034 年
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲：依產品類型分類，2021-2034 年
    • 歐洲：依劑型分類，2021-2034 年
    • 歐洲：依製造商分類，2021-2034 年
    • 歐洲：依申請，2021-2034 年
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 荷蘭
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 亞太地區：依產品類型分類，2021-2034 年
    • 亞太地區：依類型分類，2021-2034 年
    • 亞太地區：依製造商分類，2021–2034 年
    • 亞太地區：依應用分類，2021-2034 年
    • 中國
    • 印度
    • 馬來西亞
    • 日本
    • 印尼
    • 韓國
    • 澳洲
    • 亞太其他地區
  • 中東和非洲
    • 中東和非洲：按產品類型分類，2021-2034 年
    • 中東和非洲：按類型分類，2021-2034 年
    • 中東和非洲：按製造商分類，2021-2034 年
    • 中東和非洲：按使用量分類，2021-2034 年
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 南非
    • 其他中東和非洲地區
  • 拉丁美洲
    • 拉丁美洲：依產品類型分類，2021-2034 年
    • 拉丁美洲：按類型分類，2021–2034 年
    • 拉丁美洲：按製造商分類，2021-2034 年
    • 拉丁美洲：依使用量分類，2021-2034 年
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他拉丁美洲

第10章 競爭格局

  • 企業擴張與收購分析
    • 業務拓展
    • 獲得
  • 夥伴關係、合作、合約、展覽

第11章：公司簡介

  • Pfizer
  • Teva Pharmaceuticals Ltd
  • GSK PLC
  • Sanofi
  • Eli Lilly and Company
  • Merck KGaA
  • AbbVie Inc.
  • F-Hoffman La Roche Ltd
  • AstraZeneca
  • Dr. Reddy's Laboratory
  • BASF Corporation
  • Sun Pharmaceuticals Industries Ltd.
  • Curia Global Inc.
  • Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd.
Product Code: PM1703

The active pharmaceutical ingredient market size is expected to reach USD 468.0 billion by 2034, according to a new study by Polaris Market Research. The report "Active Pharmaceutical Ingredient (API) Market Size, Share, Trends, Industry Analysis Report: By Product Type, Form (Aqueous, Non-Aqueous Liquid, and Dry Powder), Manufacturer Type, Application, and Region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa) - Market Forecast, 2026-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The active pharmaceutical ingredient (API) market growth is driven by increasing demand for generic drugs and over-the-counter drugs worldwide. For instance, the retail sales of over-the-counter drugs in the US have risen to 43.4 billion USD in 2023 from 14.7 billion dollar USD in 2000. This represents a significant increase of 33 billion dollar USD from 2000 to 2023. Additionally, the sales revenue of OTC drugs from 2018 to 2023 has grown by 3.6%

Increasing investments and funding from public and private capitalists are anticipated to fuel active pharmaceutical market growth. Advancements in drug formulations, production, and short drug discovery timelines have been attracting investors seeking better returns on their investments. For instance, in August 2024, Vivint Pharma, a leading injectables pharmaceutical company, announced plans to build an advanced injectables manufacturing facility in Genome Valley, Hyderabad. The company will invest $48 million in the new facility, which is expected to create 1,000 jobs and strengthen Telangana's position as a global life sciences hub. The announcement was made during a high-level meeting with Telangana's Chief Minister, Shri A. Revanth Reddy, and Minister for Industries and Commerce, Sri D. Sridhar Babu, in the US. Vivint Pharma, which already has a $8.5 million R&D center in Genome Valley, is expanding its footprint in India. The company has acquired 5.5 acres in Genome Valley, known for its world-class infrastructure and innovation ecosystem, to support its entry into international markets.

Pharmaceutical companies are major consumers and manufacturers of active pharmaceutical ingredients. Increasing investment and government incentives have led to a rise in the number of new players with innovative ideas, challenging the existing pharmaceutical giants.

Active Pharmaceutical Ingredient (API) Market Report Highlights

By form analysis, the aqueous segment is anticipated to experience substantial growth with a significant CAGR in the market. This growth is attributed to the wide range of applications of the aqueous active pharmaceutical ingredient in different forms of drugs.

In 2024, North America dominated the API market due to the established presence of several companies within the region.

The active pharmaceutical ingredient (API) market in China is projected for substantial growth due to the regulatory support and funding for biotech innovations within the country.

The key market players are Pfizer; Teva Pharmaceuticals Industries Ltd.; GSK PLC; Sanofi; Eli Lilly and Company; Merck KGaA; AbbVie Inc.; F-Hoffman La Roche Ltd; AstraZeneca; Dr. Reddy's Laboratory Ltd.; BASF Corporation; Sun Pharmaceutical Industries Ltd.; Curia Global Inc.; and Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd.

Polaris Market Research has segmented the active pharmaceutical ingredient market report based on product type, form, manufacturer type, application, and region:

By Product Type Outlook (Revenue - USD Billion, 2021-2034)

mAb

Immunoglobulin

Cytokines

Insulin

Peptide Hormones

Blood Factors

Peptide Antibiotics

Vaccines

Small Molecule Antibiotics

Highly Potent Active Pharmaceutical Ingredient (HPAPI)

Others

By Form Outlook (Revenue - USD Billion, 2021-2034)

Aqueous

Non-Aqueous Liquid

Dry Powder

By Manufacturer Type Outlook (Revenue - USD Billion, 2021-2034)

Captive

Merchant

By Application Outlook (Revenue - USD Billion, 2021-2034)

Cardiology

Oncology

CNS & Neurology

Orthopedic

Endocrinology

Pulmonology

Gastroenterology

Nephrology

Ophthalmology

Others

By Regional Outlook (Revenue - USD Billion, 2021-2034)

North America

US

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Rest of Europe

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Australia

Rest of Asia Pacific

Latin America

Argentina

Brazil

Mexico

Rest of Latin America

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Rest of the Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Active Pharmaceutical Ingredient (API) Market Insights

  • 4.1. Active Pharmaceutical Ingredient (API) Market - Market Snapshot
  • 4.2. Active Pharmaceutical Ingredient (API) Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing Investment in Pharmaceutical Sector is Driving the Market Size
      • 4.2.1.2. Increasing Number of Pipeline Drugs Are Driving the Market Growth
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Lack of Skilled Workforce
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Active Pharmaceutical Ingredient (API) Market Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Active Pharmaceutical Ingredient (API) Market, by Product Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
  • 5.3. mAb
    • 5.3.1. Global Active Pharmaceutical Ingredient (API) Market, by mAb, by Region, 2021-2034 (USD Billion)
  • 5.4. Immunoglobulin
    • 5.4.1. Global Active Pharmaceutical Ingredient (API) Market, by Immunoglobulin, by Region, 2021-2034 (USD Billion)
  • 5.5. Cytokines
    • 5.5.1. Global Active Pharmaceutical Ingredient (API) Market, by Cytokines, by Region, 2021-2034 (USD Billion)
  • 5.6. Insulin
    • 5.6.1. Global Active Pharmaceutical Ingredient (API) Market, by Insulin, by Region, 2021-2034 (USD Billion)
  • 5.7. Peptide Hormones
    • 5.7.1. Global Active Pharmaceutical Ingredient (API) Market, by Peptide Hormones, by Region, 2021-2034 (USD Billion)
  • 5.8. Blood Factors
    • 5.8.1. Global Active Pharmaceutical Ingredient (API) Market, by Blood Factors, by Region, 2021-2034 (USD Billion)
  • 5.9. Peptide Antibiotics
    • 5.9.1. Global Active Pharmaceutical Ingredient (API) Market, by Peptide Antibiotics, by Region, 2021-2034 (USD Billion)
  • 5.10. Vaccines
    • 5.10.1. Global Active Pharmaceutical Ingredient (API) Market, by Vaccines, by Region, 2021-2034 (USD Billion)
  • 5.11. Small Molecule Antibiotics
    • 5.11.1. Global Active Pharmaceutical Ingredient (API) Market, by Small Molecule Antibiotics, by Region, 2021-2034 (USD Billion)
  • 5.12. Highly Potent Active Pharmaceutical Ingredient (HPAPI)
    • 5.12.1. Global Active Pharmaceutical Ingredient (API) Market, by Highly Potent Active Pharmaceutical Ingredient (HPAPI), by Region, 2021-2034 (USD Billion)
  • 5.13. Others
    • 5.13.1. Global Active Pharmaceutical Ingredient (API) Market, by Others, by Region, 2021-2034 (USD Billion)

6. Global Active Pharmaceutical Ingredient (API) Market, by Form

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
  • 6.3. Aqueous
    • 6.3.1. Global Active Pharmaceutical Ingredient (API) Market, by Aqueous, by Region, 2021-2034 (USD Billion)
  • 6.4. Non-Aqueous Liquid
    • 6.4.1. Global Active Pharmaceutical Ingredient (API) Market, by Non-Aqueous Liquid, by Region, 2021-2034 (USD Billion)
  • 6.5. Dry Powder
    • 6.5.1. Global Active Pharmaceutical Ingredient (API) Market, by Dry Powder, by Region, 2021-2034 (USD Billion)

7. Global Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
  • 7.3. Captive
    • 7.3.1. Global Active Pharmaceutical Ingredient (API) Market, by Captive, by Region, 2021-2034 (USD Billion)
  • 7.4. Merchant
    • 7.4.1. Global Active Pharmaceutical Ingredient (API) Market, by Merchant, by Region, 2021-2034 (USD Billion)

8. Global Active Pharmaceutical Ingredient (API) Market, by Application

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
  • 8.3. Cardiology
    • 8.3.1. Global Active Pharmaceutical Ingredient (API) Market, by Cardiology, by Region, 2021-2034 (USD Billion)
  • 8.4. Oncology
    • 8.4.1. Global Active Pharmaceutical Ingredient (API) Market, by Oncology, by Region, 2021-2034 (USD Billion)
  • 8.5. CNS & Neurology
    • 8.5.1. Global Active Pharmaceutical Ingredient (API) Market, by CNS & Neurology, by Region, 2021-2034 (USD Billion)
  • 8.6. Orthopedic
    • 8.6.1. Global Active Pharmaceutical Ingredient (API) Market, by Orthopedic, by Region, 2021-2034 (USD Billion)
  • 8.7. Endocrinology
    • 8.7.1. Global Active Pharmaceutical Ingredient (API) Market, by Endocrinology, by Region, 2021-2034 (USD Billion)
  • 8.8. Pulmonology
    • 8.8.1. Global Active Pharmaceutical Ingredient (API) Market, by Pulmonology, by Region, 2021-2034 (USD Billion)
  • 8.9. Gastroenterology
    • 8.9.1. Global Active Pharmaceutical Ingredient (API) Market, by Gastroenterology, by Region, 2021-2034 (USD Billion)
  • 8.10. Nephrology
    • 8.10.1. Global Active Pharmaceutical Ingredient (API) Market, by Nephrology, by Region, 2021-2034 (USD Billion)
  • 8.11. Ophthalmology
    • 8.11.1. Global Active Pharmaceutical Ingredient (API) Market, by Nephrology, by Region, 2021-2034 (USD Billion)
  • 8.12. Others
    • 8.12.1. Global Active Pharmaceutical Ingredient (API) Market, by Others, by Region, 2021-2034 (USD Billion)

9. Global Active Pharmaceutical Ingredient (API) Market, by Geography

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Active Pharmaceutical Ingredient (API) Market Assessment, By Geography, 2021-2034 (USD Billion)
  • 9.3. Active Pharmaceutical Ingredient (API) Market - North America
    • 9.3.1. North America: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
    • 9.3.2. North America: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
    • 9.3.3. North America: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
    • 9.3.4. North America: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
    • 9.3.5. Active Pharmaceutical Ingredient (API) Market - U.S.
      • 9.3.5.1. U.S.: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
      • 9.3.5.2. U.S.: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
      • 9.3.5.3. U.S.: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
      • 9.3.5.4. U.S.: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
    • 9.3.6. Active Pharmaceutical Ingredient (API) Market - Canada
      • 9.3.6.1. Canada: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
      • 9.3.6.2. Canada: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
      • 9.3.6.3. Canada: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
      • 9.3.6.4. Canada: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
  • 9.4. Active Pharmaceutical Ingredient (API) Market - Europe
    • 9.4.1. Europe: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
    • 9.4.2. Europe: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
    • 9.4.3. Europe: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
    • 9.4.4. Europe: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
    • 9.4.5. Active Pharmaceutical Ingredient (API) Market - UK
      • 9.4.5.1. UK: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
      • 9.4.5.2. UK: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
      • 9.4.5.3. UK: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
      • 9.4.5.4. UK: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
    • 9.4.6. Active Pharmaceutical Ingredient (API) Market - France
      • 9.4.6.1. France: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
      • 9.4.6.2. France: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
      • 9.4.6.3. France: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
      • 9.4.6.4. France: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
    • 9.4.7. Active Pharmaceutical Ingredient (API) Market - Germany
      • 9.4.7.1. Germany: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
      • 9.4.7.2. Germany: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
      • 9.4.7.3. Germany: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
      • 9.4.7.4. Germany: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
    • 9.4.8. Active Pharmaceutical Ingredient (API) Market - Italy
      • 9.4.8.1. Italy: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
      • 9.4.8.2. Italy: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
      • 9.4.8.3. Italy: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
      • 9.4.8.4. Italy: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
    • 9.4.9. Active Pharmaceutical Ingredient (API) Market - Spain
      • 9.4.9.1. Spain: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
      • 9.4.9.2. Spain: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
      • 9.4.9.3. Spain: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
      • 9.4.9.4. Spain: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
    • 9.4.10. Active Pharmaceutical Ingredient (API) Market - Netherlands
      • 9.4.10.1. Netherlands: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
      • 9.4.10.2. Netherlands: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
      • 9.4.10.3. Netherlands: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
      • 9.4.10.4. Netherlands: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
    • 9.4.11. Active Pharmaceutical Ingredient (API) Market - Russia
      • 9.4.11.1. Russia: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
      • 9.4.11.2. Russia: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
      • 9.4.11.3. Russia: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
      • 9.4.11.4. Russia: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
    • 9.4.12. Active Pharmaceutical Ingredient (API) Market - Rest of Europe
      • 9.4.12.1. Rest of Europe: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
      • 9.4.12.2. Rest of Europe: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
      • 9.4.12.3. Rest of Europe: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
      • 9.4.12.4. Rest of Europe: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
  • 9.5. Active Pharmaceutical Ingredient (API) Market - Asia Pacific
    • 9.5.1. Asia Pacific: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
    • 9.5.2. Asia Pacific: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
    • 9.5.3. Asia Pacific: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
    • 9.5.4. Asia Pacific: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
    • 9.5.5. Active Pharmaceutical Ingredient (API) Market - China
      • 9.5.5.1. China: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
      • 9.5.5.2. China: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
      • 9.5.5.3. China: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
      • 9.5.5.4. China: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
    • 9.5.6. Active Pharmaceutical Ingredient (API) Market - India
      • 9.5.6.1. India: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
      • 9.5.6.2. India: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
      • 9.5.6.3. India: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
      • 9.5.6.4. India: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
    • 9.5.7. Active Pharmaceutical Ingredient (API) Market - Malaysia
      • 9.5.7.1. Malaysia: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
      • 9.5.7.2. Malaysia: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
      • 9.5.7.3. Malaysia: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
      • 9.5.7.4. Malaysia: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
    • 9.5.8. Active Pharmaceutical Ingredient (API) Market - Japan
      • 9.5.8.1. Japan: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
      • 9.5.8.2. Japan: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
      • 9.5.8.3. Japan: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
      • 9.5.8.4. Japan: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
    • 9.5.9. Active Pharmaceutical Ingredient (API) Market - Indonesia
      • 9.5.9.1. Indonesia: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
      • 9.5.9.2. Indonesia: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
      • 9.5.9.3. Indonesia: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
      • 9.5.9.4. Indonesia: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
    • 9.5.10. Active Pharmaceutical Ingredient (API) Market - South Korea
      • 9.5.10.1. South Korea: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
      • 9.5.10.2. South Korea: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
      • 9.5.10.3. South Korea: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
      • 9.5.10.4. South Korea: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
    • 9.5.11. Active Pharmaceutical Ingredient (API) Market - Australia
      • 9.5.11.1. Australia: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
      • 9.5.11.2. Australia: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
      • 9.5.11.3. Australia: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
      • 9.5.11.4. Australia: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
    • 9.5.12. Active Pharmaceutical Ingredient (API) Market - Rest of Asia Pacific
      • 9.5.12.1. Rest of Asia Pacific: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
      • 9.5.12.2. Rest of Asia Pacific: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
      • 9.5.12.3. Rest of Asia Pacific: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
      • 9.5.12.4. Rest of Asia Pacific: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
  • 9.6. Active Pharmaceutical Ingredient (API) Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
    • 9.6.2. Middle East & Africa: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
    • 9.6.3. Middle East & Africa: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
    • 9.6.4. Middle East & Africa: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
    • 9.6.5. Active Pharmaceutical Ingredient (API) Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
      • 9.6.5.2. Saudi Arabia: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
      • 9.6.5.3. Saudi Arabia: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
      • 9.6.5.4. Saudi Arabia: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
    • 9.6.6. Active Pharmaceutical Ingredient (API) Market - UAE
      • 9.6.6.1. UAE: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
      • 9.6.6.2. UAE: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
      • 9.6.6.3. UAE: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
      • 9.6.6.4. UAE: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
    • 9.6.7. Active Pharmaceutical Ingredient (API) Market - Israel
      • 9.6.7.1. Israel: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
      • 9.6.7.2. Israel: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
      • 9.6.7.3. Israel: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
      • 9.6.7.4. Israel: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
    • 9.6.8. Active Pharmaceutical Ingredient (API) Market - South Africa
      • 9.6.8.1. South Africa: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
      • 9.6.8.2. South Africa: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
      • 9.6.8.3. South Africa: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
      • 9.6.8.4. South Africa: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
    • 9.6.9. Active Pharmaceutical Ingredient (API) Market - Rest of Middle East & Africa
      • 9.6.9.1. Rest of Middle East & Africa: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
      • 9.6.9.2. Rest of Middle East & Africa: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
      • 9.6.9.3. Rest of Middle East & Africa: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
      • 9.6.9.4. Rest of Middle East & Africa: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
  • 9.7. Active Pharmaceutical Ingredient (API) Market - Latin America
    • 9.7.1. Latin America: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
    • 9.7.2. Latin America: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
    • 9.7.3. Latin America: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
    • 9.7.4. Latin America: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
    • 9.7.5. Active Pharmaceutical Ingredient (API) Market - Mexico
      • 9.7.5.1. Mexico: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
      • 9.7.5.2. Mexico: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
      • 9.7.5.3. Mexico: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
      • 9.7.5.4. Mexico: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
    • 9.7.6. Active Pharmaceutical Ingredient (API) Market - Brazil
      • 9.7.6.1. Brazil: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
      • 9.7.6.2. Brazil: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
      • 9.7.6.3. Brazil: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
      • 9.7.6.4. Brazil: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
    • 9.7.7. Active Pharmaceutical Ingredient (API) Market - Argentina
      • 9.7.7.1. Argentina: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
      • 9.7.7.2. Argentina: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
      • 9.7.7.3. Argentina: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
      • 9.7.7.4. Argentina: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
    • 9.7.8. Active Pharmaceutical Ingredient (API) Market - Rest of Latin America
      • 9.7.8.1. Rest of Latin America: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
      • 9.7.8.2. Rest of Latin America: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
      • 9.7.8.3. Rest of Latin America: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
      • 9.7.8.4. Rest of Latin America: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. Pfizer
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. Teva Pharmaceuticals Ltd
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. GSK PLC
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. Sanofi
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. Eli Lilly and Company
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. Merck KGaA
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. AbbVie Inc.
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. F-Hoffman La Roche Ltd
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. AstraZeneca
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. Dr. Reddy's Laboratory
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development
  • 11.11. BASF Corporation
    • 11.11.1. Company Overview
    • 11.11.2. Financial Performance
    • 11.11.3. Product Benchmarking
    • 11.11.4. Recent Development
  • 11.12. Sun Pharmaceuticals Industries Ltd.
    • 11.12.1. Company Overview
    • 11.12.2. Financial Performance
    • 11.12.3. Product Benchmarking
    • 11.12.4. Recent Development
  • 11.13. Curia Global Inc.
    • 11.13.1. Company Overview
    • 11.13.2. Financial Performance
    • 11.13.3. Product Benchmarking
    • 11.13.4. Recent Development
  • 11.14. Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd.
    • 11.14.1. Company Overview
    • 11.14.2. Financial Performance
    • 11.14.3. Product Benchmarking
    • 11.14.4. Recent Development

List of Tables:

  • Table 1 Global Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
  • Table 2 Global Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
  • Table 3 Global Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
  • Table 4 Global Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
  • Table 5 North America: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
  • Table 6 North America: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
  • Table 7 North America: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
  • Table 8 North America: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
  • Table 9 U.S.: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
  • Table 10 U.S.: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
  • Table 11 U.S.: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
  • Table 12 U.S.: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
  • Table 13 Canada: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
  • Table 14 Canada: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
  • Table 15 Canada: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
  • Table 16 Canada: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
  • Table 17 Europe: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
  • Table 18 Europe: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
  • Table 19 Europe: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
  • Table 20 Europe: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
  • Table 21 UK: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
  • Table 22 UK: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
  • Table 23 UK: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
  • Table 24 UK: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
  • Table 25 France: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
  • Table 26 France: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
  • Table 27 France: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
  • Table 28 France: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
  • Table 29 Germany: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
  • Table 30 Germany: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
  • Table 31 Germany: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
  • Table 32 Germany: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
  • Table 33 Italy: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
  • Table 34 Italy: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
  • Table 35 Italy: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
  • Table 36 Italy: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
  • Table 37 Spain: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
  • Table 38 Spain: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
  • Table 39 Spain: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
  • Table 40 Spain: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
  • Table 41 Netherlands: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
  • Table 42 Netherlands: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
  • Table 43 Netherlands: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
  • Table 44 Netherlands: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
  • Table 45 Russia: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
  • Table 46 Russia: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
  • Table 47 Russia: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
  • Table 48 Russia: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
  • Table 49 Rest of Europe: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
  • Table 50 Rest of Europe: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
  • Table 51 Rest of Europe: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
  • Table 52 Rest of Europe: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
  • Table 53 Asia Pacific: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
  • Table 54 Asia Pacific: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
  • Table 55 Asia Pacific: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
  • Table 56 Asia Pacific: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
  • Table 57 China: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
  • Table 58 China: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
  • Table 59 China: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
  • Table 60 China: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
  • Table 61 India: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
  • Table 62 India: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
  • Table 63 India: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
  • Table 64 India: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
  • Table 65 Malaysia: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
  • Table 66 Malaysia: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
  • Table 67 Malaysia: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
  • Table 68 Malaysia: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
  • Table 69 Japan: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
  • Table 70 Japan: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
  • Table 71 Japan: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
  • Table 72 Japan: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
  • Table 73 Indonesia: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
  • Table 74 Indonesia: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
  • Table 75 Indonesia: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
  • Table 76 Indonesia: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
  • Table 77 South Korea: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
  • Table 78 South Korea: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
  • Table 79 South Korea: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
  • Table 80 South Korea: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
  • Table 81 Australia: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
  • Table 82 Australia: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
  • Table 83 Australia: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
  • Table 84 Australia: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
  • Table 85 Rest of Asia Pacific: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
  • Table 86 Rest of Asia Pacific: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
  • Table 87 Rest of Asia Pacific: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
  • Table 88 Rest of Asia Pacific: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
  • Table 89 Middle East & Africa: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
  • Table 90 Middle East & Africa: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
  • Table 91 Middle East & Africa: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
  • Table 92 Middle East & Africa: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
  • Table 93 Saudi Arabia: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
  • Table 94 Saudi Arabia: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
  • Table 95 Saudi Arabia: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
  • Table 96 Saudi Arabia: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
  • Table 97 UAE: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
  • Table 98 UAE: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
  • Table 99 UAE: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
  • Table 100 UAE: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
  • Table 101 Israel: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
  • Table 102 Israel: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
  • Table 103 Israel: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
  • Table 104 Israel: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
  • Table 105 South Africa: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
  • Table 106 South Africa: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
  • Table 107 South Africa: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
  • Table 108 South Africa: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
  • Table 109 Rest of Middle East & Africa: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
  • Table 110 Rest of Middle East & Africa: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
  • Table 111 Rest of Middle East & Africa: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
  • Table 112 Rest of Middle East & Africa: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
  • Table 113 Latin America: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
  • Table 114 Latin America: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
  • Table 115 Latin America: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
  • Table 116 Latin America: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
  • Table 117 Mexico: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
  • Table 118 Mexico: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
  • Table 119 Mexico: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
  • Table 120 Mexico: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
  • Table 121 Brazil: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
  • Table 122 Brazil: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
  • Table 123 Brazil: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
  • Table 124 Brazil: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
  • Table 125 Argentina: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
  • Table 126 Argentina: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
  • Table 127 Argentina: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
  • Table 128 Argentina: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)
  • Table 129 Rest of Latin America: Active Pharmaceutical Ingredient (API) Market, by Product Type, 2021-2034 (USD Billion)
  • Table 130 Rest of Latin America: Active Pharmaceutical Ingredient (API) Market, by Form, 2021-2034 (USD Billion)
  • Table 131 Rest of Latin America: Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2021-2034 (USD Billion)
  • Table 132 Rest of Latin America: Active Pharmaceutical Ingredient (API) Market, by Application, 2021-2034 (USD Billion)

List of Figures:

  • Figure 1. Global Active Pharmaceutical Ingredient (API) Market, 2021-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Product Type
  • Figure 7. Global Active Pharmaceutical Ingredient (API) Market, by Product Type, 2025 & 2034 (USD Billion)
  • Figure 8. Market by Form
  • Figure 9. Global Active Pharmaceutical Ingredient (API) Market, by Form, 2025 & 2034 (USD Billion)
  • Figure 10. Market by Manufacturer Type
  • Figure 11. Global Active Pharmaceutical Ingredient (API) Market, by Manufacturer Type, 2025 & 2034 (USD Billion)
  • Figure 12. Market by Application
  • Figure 13. Global Active Pharmaceutical Ingredient (API) Market, by Application, 2025 & 2034 (USD Billion)